Skip to main content

Table 1 Characteristics of included studies

From: Efficacy and safety of botulinum toxin-A in writer’s cramp: a systematic review, meta-analysis, and meta-regression

Study

Study design

Study population

Age of study population

Duration of WC

Sample size

Rajan, 2021

RCT

DT, C

46.0 ± 18.6

8.5 ± 5.8

15 (DT), 15 (C)

Park, 2019

RCT

WC

62.0 ± 6.0

21.0 ± 3.0

6 (WC), 6 (C)

Srivantichapoom, 2016

Observational

WC, C

47.9 ± 6.3

19.1 ± 5.9

8 (WC)

Jackman, 2016

Observational

WC (responders), C (non-responders)

59.8

12.3 ± 11.2

5 (WC: responders), 4 (WC: non responders)

Likachev, 2016

Observational

WC

39.7 ± 4.5

5.8 ± 0.65

29 (WC)

Zeuner, 2013

Observational

WC, C

57.1 ± 10.7

10.9 ± 8.8

10 (WC), 18 (C)

Contarino, 2007

RCT

WC

36.9 ± 9.7

9.3 ± 8.9

29 (WC) 10 (C)

Kruisdijk, 2007

RCT

WC

47.60 ± 11.24

7.38 ± 6.22

20 (WC), 20 (C)

Djebbdari, 2005

Observational

WC

46.1 ± 14.0

7.6 ± 8.1

47 (WC),

Marion, 2003

Observational

WC

35.6 ± 43.13

4.6 ± 13.43

167 (WC)

Behari, 1999

Observational

WC

35.75 ± 23.33

3.64 ± 8.48

16 (WC)

Chen, 1999

RCT

WC

31.6

8 (WC)

Wissel, 1996

Observational

WC

34.8

12.3

31

Turjanski, 1996

Observational

WC, 1 MC

36

45 (WC)

Cole, 1995

Observational

WC

49.4

8.5 ± 5.16

10 (6 WC, 2TC, 2MC)

Tsui, 1993

RCT

WC, C

41.75

5.15

20

Rivest, 1991

Observational

WC

43

9

12 (WC)

Poungvarin, 1991

Observational

WC

36.8 ± 10.22

5.88 ± 7.14

25(WC)

Cohen, 1989

Observational

WC

38

7

19 (WC)

  1. WC writer’s cramp, C control group, RCT randomised controlled trial, MC musicians dystonia